Literature DB >> 29611089

Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.

LeChauncy D Woodard1,2, Omolola E Adepoju3,4, Amber B Amspoker3,4, Salim S Virani3,4, David J Ramsey3,4, Laura A Petersen3,4, Lindsey A Jones3, Lea Kiefer3,4, Praveen Mehta5, Aanand D Naik3,4.   

Abstract

BACKGROUND: Given its widespread dissemination across primary care, the Veterans Health Administration (VA) is an ideal setting to examine the impact of the patient-centered medical home (PCMH) on diabetes outcomes.
OBJECTIVE: To assess the impact of PCMH implementation on diabetes outcomes among patients receiving care in the Veterans Health Administration.
DESIGN: Retrospective cohort analysis and multilevel logistic regression. PATIENTS: Twenty thousand eight hundred fifty-eight patients in one Midwest VA network who had a diabetes diagnosis in both 2009 and 2012 and who received primary care between October 1, 2008 and September 30, 2009. MAIN MEASURES: Glycemic and lipid control using VA quality indicators [hemoglobin (Hb) A1c < 9%, low-density lipoprotein cholesterol (LDL-C) < 100 mg/dL]. KEY
RESULTS: Odds of glycemic control were lower in 2012 than 2009 (OR = 0.72, 95% CI = 0.67-0.77, p  < 0.001), and this change in control over time varied by race (OR of the interaction between time and race = 1.18, 95% CI = 1.02-1.36, p  = 0.028). While the disparity in glycemic control between white and black patients persisted post-PCMH, the magnitude of the disparity was smaller in 2012 compared to 2009 (2012: OR = 1.32, 95% CI = 1.18-1.47, p  < 0.0001 and 2009: OR = 1.59, 95% CI = 1.39-1.82, p  < 0.0001). Odds of lipid control did not significantly change between 2009 and 2012 and change did not vary by race and/or gender.
CONCLUSIONS: Although there were no significant improvements in odds of lipid control, and odds of glycemic control decreased following PCMH implementation, there was evidence of reduced racial disparities in glycemic control post-PCMH implementation.

Entities:  

Keywords:  diabetes; disparities; patient-centered outcomes research; race and ethnicity; veterans

Mesh:

Substances:

Year:  2018        PMID: 29611089      PMCID: PMC6082213          DOI: 10.1007/s11606-018-4386-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  36 in total

1.  Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project.

Authors:  Carlos Roberto Jaén; Robert L Ferrer; William L Miller; Raymond F Palmer; Robert Wood; Marivel Davila; Elizabeth E Stewart; Benjamin F Crabtree; Paul A Nutting; Kurt C Stange
Journal:  Ann Fam Med       Date:  2010       Impact factor: 5.166

2.  Diabetes care among veteran women with disability.

Authors:  Chin-Lin Tseng; Usha Sambamoorthi; Anjali Tiwari; Mangala Rajan; Patricia Findley; Leonard Pogach
Journal:  Womens Health Issues       Date:  2006 Nov-Dec

3.  Impact of comorbidity type on measures of quality for diabetes care.

Authors:  Lechauncy D Woodard; Tracy Urech; Cassie R Landrum; Degang Wang; Laura A Petersen
Journal:  Med Care       Date:  2011-06       Impact factor: 2.983

4.  Racial And Ethnic Disparities Persist At Veterans Health Administration Patient-Centered Medical Homes.

Authors:  Donna L Washington; W Neil Steers; Alexis K Huynh; Susan M Frayne; Uchenna S Uchendu; Deborah Riopelle; Elizabeth M Yano; Fay S Saechao; Katherine J Hoggatt
Journal:  Health Aff (Millwood)       Date:  2017-06-01       Impact factor: 6.301

5.  Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes.

Authors:  Laura A Petersen; Kenneth Pietz; LeChauncy D Woodard; Margaret Byrne
Journal:  Med Care       Date:  2005-01       Impact factor: 2.983

6.  Data resources in the Department of Veterans Affairs.

Authors:  Charles Maynard; Michael K Chapko
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Implementation of the patient-centered medical home in the Veterans Health Administration: associations with patient satisfaction, quality of care, staff burnout, and hospital and emergency department use.

Authors:  Karin M Nelson; Christian Helfrich; Haili Sun; Paul L Hebert; Chuan-Fen Liu; Emily Dolan; Leslie Taylor; Edwin Wong; Charles Maynard; Susan E Hernandez; William Sanders; Ian Randall; Idamay Curtis; Gordon Schectman; Richard Stark; Stephan D Fihn
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

Review 8.  The medical home: growing evidence to support a new approach to primary care.

Authors:  Thomas C Rosenthal
Journal:  J Am Board Fam Med       Date:  2008 Sep-Oct       Impact factor: 2.657

9.  Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.

Authors:  Varsha G Vimalananda; Donald R Miller; Timothy P Hofer; Robert G Holleman; Mandi L Klamerus; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

Review 10.  Patient-centered medical home and diabetes.

Authors:  Trajko Bojadzievski; Robert A Gabbay
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

View more
  3 in total

1.  Capsule Commentary on Woodard et al., Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.

Authors:  Lisa Stehno-Bittel; Lisa VanHoose
Journal:  J Gen Intern Med       Date:  2018-08       Impact factor: 5.128

2.  Impact of team configuration and team stability on primary care quality.

Authors:  Sylvia J Hysong; Amber B Amspoker; Ashley M Hughes; Lechauncy Woodard; Frederick L Oswald; Laura A Petersen; Houston F Lester
Journal:  Implement Sci       Date:  2019-03-06       Impact factor: 7.327

3.  Explaining racial-ethnic differences in hypertension and diabetes control among veterans before and after patient-centered medical home implementation.

Authors:  Lucinda B Leung; W Neil Steers; Katherine J Hoggatt; Donna L Washington
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.